Brian G. Sutherland

发表

Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.

M. Drangova, A. Adams, C. Pin, 2015, Endocrinology.

Peroxisome Proliferator–Activated Receptor &dgr; Agonist GW1516 Attenuates Diet-Induced Aortic Inflammation, Insulin Resistance, and Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice

J. Pickering, R. Tirona, M. Huff, 2014, Arteriosclerosis, thrombosis, and vascular biology.

Inhibition of both the apical sodium-dependent bile acid transporter and HMG-CoA reductase markedly enhances the clearance of LDL apoB Published, JLR Papers in Press, February 1, 2003. DOI 10.1194/jlr.M200482-JLR200

E. Krul, J. Burnett, P. Barrett, 2003, Journal of Lipid Research.

Naringenin prevents dyslipidemia, apoB overproduction and hyperinsulinemia in LDL-receptor null mice with diet-induced insulin resistance. Running title: Naringenin prevents dyslipidemia

R. Hegele, J. Markle, E. Allister, 2009 .

Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr−/− mice[S]

M. Huff, R. Gros, D. E. Telford, 2013, Journal of Lipid Research.

The marine compound and elongation factor 1A1 inhibitor, didemnin B, provides benefit in western diet-induced non-alcoholic fatty liver disease.

N. Borradaile, R. Jacobs, Rennian Wang, 2020, Pharmacological research.

Naringenin Decreases Progression of Atherosclerosis by Improving Dyslipidemia in High-Fat–Fed Low-Density Lipoprotein Receptor–Null Mice

M. Huff, C. Sawyez, S. Whitman, 2010, Arteriosclerosis, thrombosis, and vascular biology.

The molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatins⃞ Published, JLR Papers in Press, November 27, 2006.

P. Barrett, M. Huff, D. E. Telford, 2007, Journal of Lipid Research.

A Novel Inhibitor of Oxidosqualene:Lanosterol Cyclase Inhibits Very Low–Density Lipoprotein Apolipoprotein B100 (ApoB100) Production and Enhances Low-Density Lipoprotein ApoB100 Catabolism Through Marked Reduction in Hepatic Cholesterol Content

O. Morand, P. Barrett, J. Aebi, 2005, Arteriosclerosis, thrombosis, and vascular biology.

Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in Ldlr−/− Mice by Treatment With the ATP-Citrate Lyase Inhibitor Bempedoic Acid

Stephen L. Pinkosky, M. Huff, D. E. Telford, 2017, Arteriosclerosis, thrombosis, and vascular biology.

Two-Week Isocaloric Time-Restricted Feeding Decreases Liver Inflammation without Significant Weight Loss in Obese Mice with Non-Alcoholic Fatty Liver Disease

N. Borradaile, R. Jacobs, Rennian Wang, 2020, International journal of molecular sciences.

The citrus flavonoid nobiletin confers protection from metabolic dysregulation in high-fat-fed mice independent of AMPK[S]

G. Steinberg, M. Huff, D. E. Telford, 2020, Journal of Lipid Research.

Nobiletin Prevents High-Fat Diet-Induced Dysregulation of Intestinal Lipid Metabolism and Attenuates Postprandial Lipemia

M. Huff, D. E. Telford, Jane Y. Edwards, 2021, Arteriosclerosis, thrombosis, and vascular biology.

Nobiletin Attenuates VLDL Overproduction, Dyslipidemia, and Atherosclerosis in Mice With Diet-Induced Insulin Resistance

Justin Lee, A. Marette, E. Allister, 2011, Diabetes.

PPARδ activation attenuates hepatic steatosis in Ldlr−/− mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity

B. Kemp, G. Steinberg, M. Huff, 2014, Journal of Lipid Research.

Naringenin Supplementation to a Chow Diet Enhances Energy Expenditure and Fatty Acid Oxidation, and Reduces Adiposity in Lean, Pair‐Fed Ldlr−/− Mice

M. Huff, D. E. Telford, C. Sawyez, 2019, Molecular nutrition & food research.

Vitamin D intervention does not improve vascular regeneration in diet-induced obese male mice with peripheral ischemia.

N. Borradaile, J. Pickering, Z. Nong, 2019, The Journal of nutritional biochemistry.

Naringenin Prevents Dyslipidemia, Apolipoprotein B Overproduction, and Hyperinsulinemia in LDL Receptor–Null Mice With Diet-Induced Insulin Resistance

R. Hegele, E. Allister, M. Huff, 2009, Diabetes.

Naringenin enhances the regression of atherosclerosis induced by a chow diet in Ldlr-/- mice.

M. Huff, D. E. Telford, C. Sawyez, 2019, Atherosclerosis.

Intervention with citrus flavonoids reverses obesity and improves metabolic syndrome and atherosclerosis in obese Ldlr−/− mice[S]

M. Drangova, M. Huff, D. E. Telford, 2018, Journal of Lipid Research.

Treatment with didemnin B, an elongation factor 1A inhibitor, improves hepatic lipotoxicity in obese mice

N. Borradaile, R. Jacobs, C. Sawyez, 2016, Physiological reports.

Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient (LDLR+/− and LDLR−/−) Yucatan Miniature Pigs

J. Pickering, P. Barrett, M. Huff, 2018, Arteriosclerosis, thrombosis, and vascular biology.

Niacin promotes revascularization and recovery of limb function in diet‐induced obese mice with peripheral ischemia

N. Borradaile, J. Pickering, Z. Nong, 2016, Pharmacology research & perspectives.

Intervention with citrus flavonoids reverses obesity and improves Intervention with citrus flavonoids reverses obesity and improves metabolic syndrome and atherosclerosis in obese Ldlr metabolic syndrome and atherosclerosis in obese Ldlr // mice mice

M. Drangova, D. E. Telford, C. Sawyez, 2021 .

Abstract 686: Intervention with Naringenin Enhances Weight Loss, Potentiates Improvements in Metabolic Dysregulation and Halts Progression of Atherosclerosis Induced by a High-Fat Diet in LDLr-/- Mice.

M. Huff, A. Burke, Brian G. Sutherland, 2015 .

Abstract 67: Intervention With Citrus Flavonoids Reverses Existing Metabolic Disorders and Attenuates the Progression of Advanced Atherosclerosis in High Fat--Fed LDLr-/- Mice

M. Drangova, M. Huff, J. Umoh, 2014 .